Abstract
A retinal nerve fiber layer (RNFL) evaluation and automated perimetry were performed in 41 eyes of patients with the human immunodeficiency virus (HIV) but without previous retinal or optic nerve disease. Cases with diffuse atrophy in RNFL represented 8%, 62.5%, and 77% in groups 1 through 3, respectively. Normal visual fields were present in 33% in group 1, 12.5% in group 2, and 7.5% in group 3.
Similar content being viewed by others
References
Palestine AG, Rodrigues MM, Macher AM. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984;9:1092.
Holland GN, Pepose JS, Petit TH. Acquired immunodeficiency syndrome: ocular manifestations. Ophthalmology. 1983;90:859.
Tenhula WX, Xu SH, Madigan MC, Freeman KA, Sandun AA. Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:14–20.
Quinceno JI, Capparelli E, Sadun AA. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:8–13.
Honrubia FM, Ferrer E, Torron C, Gonzalez I, Study of the RNFL in patients with acquired immunodeficiency syndrome. Ger J Ophthalmol. 1994;3:1–4.
Centers for Disease Control. Classification system for human lymphotropic virus type III-lymphadenopathy associated virus infections. MMWR. 1986;35:334–338.
Caprioli J. Automated perimetry in glaucoma. Am J Ophthalmol. 1991;11:235–239.
Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. HIV-I coat protein neurotoxicity prevented by calcium channel antagonist. Science. 1990;248:364–367.
Quigley HA, Dunkelberg GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1984;107:453–464.
Abecia E, Honrubia FM. RNFL defects and automated perimetry. Int Opthalmol. 1992;16:239–242.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Honrubia, F.M., Torrón, C., Ferrer, E. et al. Exploration of retinal nerve fiber layer and visual field in patients with human immunodeficiency virus. Ann Ophthalmol 32, 289–294 (2000). https://doi.org/10.1007/s12009-000-0084-4
Issue Date:
DOI: https://doi.org/10.1007/s12009-000-0084-4